|
Maternal comorbid conditions and the risk of pediatric cancer |
University of North Texas |
Northwestern Mutual Foundation |
|
Using rapid protein degradation to determine the effect of RUNX1 loss-of-function on DNA damage accumulation and repair |
Albert Einstein College of Medicine |
Northwestern Mutual Foundation |
|
Neuronal Regulation of Pediatric Brain Tumor Growth
|
Washington University |
Northwestern Mutual Foundation |
|
Understanding the association between genetic polymorphisms and adverse events during therapy for acute lymphoblastic leukemia
|
Emory University |
Northwestern Mutual Foundation |
|
Identification and characterization of non-P53 stress pathways in Shwachman-Diamond syndrome |
The Cleveland Clinic Foundation |
Northwestern Mutual Foundation |
|
Synthetic Gene Expression Regulatory Switch engineered CAR T cells for children with cancer
|
Baylor College of Medicine |
Northwestern Mutual Foundation |
|
FGFR1 alterations in pediatric gliomas
|
Dana-Farber Cancer Institute |
Northwestern Mutual Foundation |
|
Structural rearrangement signatures as novel biomarkers for homologous recombination deficiency in cancer
|
Dana-Farber Cancer Institute |
Northwestern Mutual Foundation |
|
Investigating the Role of the MYCN Oncogene in Regulating Chemokine Expression in Neuroblastoma |
Children’s Hospital of Philadelphia |
Northwestern Mutual Foundation |
|
Mutagenesis and disease progression in RUNX1 mutant blood stem cells is caused by inflammation-induced hyperactive signaling and supraphysiological mitochondrial ROS |
St. Jude Children’s Research Hospital |
The RUNX1 Research Program |